'Solid tumors' presentation slideshows

Neoplasia

Neoplasia. Cancer. Cancer. The second leading cause of death in the United States Estimated 1.45 million diagnosed 559,650 died Prostate is the most common cancer for men Breast is the most common cancer for women Excluding skin cancer

1.2k views • 95 slides

Late Effects of Childhood Cancer

Late Effects of Childhood Cancer. Pediatric Resident Education Series. Cancer incidence. Incidence: 1 in 7000 children, 0 to 14 year Likelihood of a young person reaching adulthood and being diagnosed with cancer during childhood: 1 in 300 for males 1 in 330 for females.

1.19k views • 85 slides

Disorders of Hemostasis

1.58k views • 57 slides

Jeffrey S. Ross, M.D. Department of Pathology and Laboratory Medicine Albany Medical College

783 views • 49 slides

Non-Hodgkin's Lymphoma - Long-term Survivors and Adverse Effects

Non-Hodgkin's Lymphoma - Long-term Survivors and Adverse Effects. Ron Epelbaum. Department of Oncology Rambam Medical Center Haifa, Israel. Aggressive NHL 26-73% (5 y) Low-grade NHL 50-80% (10 y). Non-Hodgkin's Lymphoma - Long-term Survival. Late Effects of Therapy.

736 views • 48 slides

????? ?????? ????? ?????? ?????

728 views • 46 slides

628 views • 46 slides

????? ?????? ????? ?????? ?????

629 views • 46 slides

Gene Expression and Gene Sequencing Using Cytology Specimens

Gene Expression and Gene Sequencing Using Cytology Specimens. 24 st Annual Advances in Cytology Cytology June 13, 2012. Jeffrey S. Ross, M.D. Albany Medical College Albany, NY rossj@mail.amc.edu. Gene Expression Profiling in Cytology. Can be performed on fresh FNA material

693 views • 41 slides

Control of Gene Expression

Control of Gene Expression. ROLE OF GENE EXPRESSION : Activation of a gene that results in a protein Cells DO NOT need to produce proteins for every code. GENOME : Complete genetic material of an individual Cells can regulate what genes get expressed. Gene expression in Prokaryotes.

574 views • 31 slides

Evaluation of Clinical Benefit in Sarcomas: Modern Imaging Modalities

535 views • 30 slides

Evaluation of Clinical Benefit in Sarcomas: Modern Imaging Modalities

445 views • 30 slides

Hypoxia-targeted Gene Therapy of Tumors using Virus-directed Enzyme- Prodrug Systems

Hypoxia-targeted Gene Therapy of Tumors using Virus-directed Enzyme- Prodrug Systems. Jeff Voegele December 4, 2012 (http :// www.markergene.com/WebNewsletter10.5.htm). Solid Tumors. Make up more than 90% of all human cancers.

354 views • 27 slides

APLASTIC ANEMIA

APLASTIC ANEMIA. Dr. Bhavesh S. Jarwani. APLASTIC ANAEMIA Empty Marrow Syndrome. Is a disorder characterized by marked reduction or absence of erythroid, granulocytic and megakaryocytic cells in the marrow with resultant pancytopenia and reduced number of CD34+ and colony forming cells.

1.77k views • 26 slides

Bone Metastases In Renal Cell Carcinoma: What Can Be Done?

Bone Metastases In Renal Cell Carcinoma: What Can Be Done?. Fred Saad, MD, FRCS Director of Urologic Oncology Professor of Surgery/Urology U of M Chair in Prostate Cancer University of Montreal. Renal Cell Cancer: Background. More than 100,000 deaths per year worldwide

999 views • 20 slides

Global Solid Tumors Treatment Market - Opportunity Analysis, 2017–2025

A solid tumor is an abnormal mass or lump of tissues without liquid or cysts. It is not necessary that tumor should always be cancerous. On the basis tumor nature, it can be classified as the malignant tumor (cancerous) and the benign tumor (non-cancerous). Based on the cell type, tumors can be classified as carcinomas, sarcomas, and lymphomas. The Solid tumors might occur in several places such as muscle, bone, and organs. Treatments for solid tumors include prevention of tumor and combination of surgery, chemotherapy, and radiation therapy. However, new forms of treatment are emerging in the market.

112 views • 8 slides

Global Solid Tumors Treatment Market - Opportunity Analysis, 2017–2025

A solid tumor is an abnormal mass or lump of tissues without liquid or cysts. It is not necessary that tumor should always be cancerous. On the basis tumor nature, it can be classified as the malignant tumor (cancerous) and the benign tumor (non-cancerous). Based on the cell type, tumors can be classified as carcinomas, sarcomas, and lymphomas. The Solid tumors might occur in several places such as muscle, bone, and organs. Treatments for solid tumors include prevention of tumor and combination of surgery, chemotherapy, and radiation therapy. However, new forms of treatment are emerging in the market.

100 views • 8 slides

Dr. Michael Har-Noy plans to start a pivotal Phase II/III randomized study of AlloStimTM in the therapy of metastatic KRAS gene positive colon tumors. Dr. Michael Har-Noy notes there is no approved third line treatment for these patients. A favorable outcome of this study would likely lead to FDA marketing approval for AlloStimTM. Dr. Michael Har-Noy intends to start the study in the United States as well as two other international sites.

158 views • 5 slides

Solid Tumor Market-Global Segments and Forecasts up to 2023

Solid tumors are formed due to aggregation of a group of abnormal tissues that do not comprise of any cyst or liquid areas within. Solid tumors can be of both types, i.e. benign (non-cancerous) as well as malignant (cancerous) in nature. Solid tumors majorly comprise of lymphomas, carcinomas, sarcomas and melanomas; whereas, all forms of leukemias usually do not cause solid tumor formation. The treatment of these solid tumors is a complex task and it requires coordinated actions of many healthcare professionals, such as, radiologists, surgeons, oncologists, radiation specialists, nurses and other professionals. Hence, most of the solid tumors are treated via radiotherapy, chemotherapy and/or surgery. However, at present, surgery is the most preferred choice of treatment for cancerous solid tumors. Chemotherapy is often utilized along with other modes of solid tumor treatment i.e. radiation and/or surgery. Several chemotherapeutic drugs are available along with a ripe pipeline of drugs that will soon be commercialized in the global market. Solid tumor market can be classified into five major segments, based on the site of origin, namely, prostrate cancer, ovarian cancer, bladder cancer, pancreatic cancer and other cancers. Browse Full Report With TOC:-http://www.transparencymarketresearch.com/solid-tumor-market.html

167 views • 5 slides

TITLE OF STUDY XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

KING HUSSEIN CANCER CENTER FROM GOOD TO GREAT Majeda Afeef RN MSN, Maha Alwawi RN, Laila Alkhoulli RN, Hiba Badran RN King Hussein Cancer Center, Amman Jordan. TITLE OF STUDY XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX PEOPLE WHO DID THE STUDYCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC

282 views • 1 slides